HeartSciences Amends Offering, Reports $6.7M Raised at Premium to Market, Seeks up to $15M to Address Going Concern
HSCS is trading near its 52-week low of $2.01 (3.5% above the low).
Summary
HeartSciences Inc. updated its Regulation A offering, disclosing $6.7 million in units already sold at a premium to the current stock price, with authorization to raise up to an additional $8.3 million, providing crucial capital for a company with a going concern warning.
Key Events · Financing and Capital Events · HSCS
-
Ongoing Capital Raise Confirmed
The company has already sold 1,912,383 units for gross proceeds of approximately $6.7 million under its existing Regulation A offering, which was originally qualified on March 10, 2025.
-
Premium Offering Price
Units were sold at an offering price of $3.50 per unit, consisting of one Series D Preferred Stock and one warrant. This price is a significant premium compared to the current common stock price of $2.08 per share, indicating strong investor interest.
-
Significant Potential Capital Infusion
HeartSciences Inc. is authorized to raise up to an additional $8.3 million, bringing the total maximum offering amount to $15 million. This represents a substantial capital raise relative to the company's current market capitalization.
-
Addressing Going Concern
The proceeds from the offering are intended for R&D, working capital, and debt repayment, which is crucial for the company given its previously disclosed going concern warning.
Analysis · HSCS · Industrial Applications And Services
HeartSciences Inc. filed a post-qualification amendment to its Regulation A offering, confirming the sale of 1,912,383 units for gross proceeds of approximately $6.7 million. This capital was raised at an offering price of $3.50 per unit, which represents a significant premium to the current market price of $2.08 per share. The company is authorized to sell up to an additional $8.3 million, bringing the total potential raise to $15 million. This substantial capital infusion is critical for the company, which previously issued a going concern warning, and the proceeds are earmarked for R&D, working capital, and debt repayment. The ability to secure funding at a premium, especially while trading near 52-week lows, indicates investor confidence despite the highly dilutive nature of the offering relative to the company's small market capitalization.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSCS was trading at $2.08 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.6M. The 52-week trading range was $2.01 to $6.47. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.